-
-
-
-
-
-
-
Increasing unusual put option volume: ALDX DKS BMBL BBBY LWLG BURL DHT SCO PATH
-
-
-
-
-
-
-
Aldeyra gets European orphan designation for retinitis pigmentosa drug
-
-
-
-
-
-
-
ALDX INQUIRY: BFA Law Notifies Aldeyra Therapeutics, Inc. Investors to Contact the Firm About Pending Investigation into the Company
-
-
-
-
-
-
-
ALDX LEGAL UPDATE: Aldeyra Therapeutics, Inc. Investors are Notified that the Company is being Investigated for Securities Violations and to Contact BFA Law
-
-
-
-
-
-
-
ALDX CLASS REMINDER: Aldeyra Therapeutics, Inc. Investors are Reminded to Contact BFA Law about the Pending Securities Investigation
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Aldeyra Therapeutics (ALDX)
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Aldeyra Therapeutics (ALDX)
-
408,251 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

